Resistance News > Library

Note: Resistance Reporter is supported by an independent educational grant from Virco Lab, Inc and is produced by Visionary Health Concepts. Virco has provided website support to house this independent program for providers.
Questions: info@resistancereporter.com.

***RESISTANCE REPORTER*^© VOL 2, ISSUE 2 (Release date: May. 05, 2008)**

Selections from the 6th European HIV Drug Resistance Workshop (EHDRW); 26-28 March, 2008; Budapest, Hungary

***RESISTANCE REPORTER*^© VOL 2, ISSUE 1 (Release date: Mar. 10, 2008)**

Selections from the 2008 Conference on Retroviruses and Opportunistic Infections (CROI)

***RESISTANCE REPORTER*^© VOL 1, ISSUE 6 (Release date: Jan. 09, 2008)**

Selection from the Targeting HIV Entry: 3rd International Workshop, December 7-8, 2007, Washington, DC.

***RESISTANCE REPORTER*^© VOL 1, ISSUE 5 (Release date: Oct. 26, 2007)**

Select presentations from 2007 ICAAC and IDSA related to (1) FDA-approved agents and the importance of treating patients with at least 2 active agents and (2) new agents in development and the importance of treating patients with at least 2 active agents.

***RESISTANCE REPORTER*^© VOL 1, ISSUE 4 (Release date: Sep 27, 2007)**

The International AIDS Society Conference 2007

***RESISTANCE REPORTER*^© VOL 1, ISSUE 3 (Release date: Aug 09, 2007)**

XVI International HIV Drug Resistance Workshop, June 12-16, 2007.

***RESISTANCE REPORTER*^© VOL 1, ISSUE 2 (Release date: May 30, 2007)**

Journal Review: Covering (1) select articles related to factors that support changing or maintaining treatment in patients with incomplete vial suppression and (2) articles related to the process of determining which patients will benefit from new treatments.

***RESISTANCE REPORTER*^© VOL 1, ISSUE 1 (Release date: March 23, 2007)**

Select Presentations: 14^TH CROI (Conference on Retroviruses and Opportunistic Infections): Feb. 25-28, 2007, Los Angeles, CA: CROI 2007 related to (1) the epidemiology of transmitted HIV drug resistance and effects of specific baseline resistance, (2) new ART.

Click here to continue to receive announcements when new issues of Resistance Reporter are available!

If you have any questions about participating in this program, please call us at 1-866-312-2449 (8AM - 5PM CT) or email us at resist-hiv@allscripts.com

© Virco Lab, Inc. 1995-2008. All rights reserved. Your use of the information on this site is subject to our Legal Notice. Please see our Privacy Policy. This site is published by Virco Lab, Inc. which is solely responsible for its contents.

This information is intended for the use of our healthcare professionals in the United States of America only.

This site was last modified on May 13 2008 at 11:43:51 EDT.

Powered By Healthy Planet